For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

A phase 3 trial of bevacizumab in ovarian cancer

Type
D - Journal article
Title of journal
New England Journal of Medicine
Article number
-
Volume number
365
Issue number
26
First page of article
2484
ISSN of journal
0028-4793
Year of publication
2011
URL
-
Number of additional authors
25
Additional information

The author made a substantial contribution to the organisation of the conduct of the study and to carrying out the study (including acquisition of study data). The author helped critique output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
218
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-